NARA Discovery
Article Details
← Back to Search Results
Journal Article

Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro

Keshav Raj Paudel; Dvya Delilaa Clarence; Nisha Panth; Bikash Manandhar; Gabriele De Rubis; Hari Prasad Devkota; Gaurav Gupta; Flavia C. Zacconi; Kylie A. Williams; Lisa G. Pont; Sachin Kumar Singh; Majid Ebrahimi Warkiani; Jon Adams; Ronan MacLoughlin; Brian G. Oliver; Dinesh Kumar Chellappan; Philip Michael Hansbro; Kamal Dua
Naunyn-Schmiedeberg's Archives of Pharmacology · Vol. 397, Issue 4 · pp. 2465-2483 · 2024

Abstract

The purpose of this study was to evaluate the potential of zerumbone-loaded liquid crystalline nanoparticles (ZER-LCNs) in the protection of broncho-epithelial cells and alveolar macrophages against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro . The effect of the treatment of ZER-LCNs on in vitro cell models of cigarette smoke extract (CSE)-treated mouse RAW264.7 and human BCi-NS1.1 basal epithelial cell lines was evaluated for their anti-inflammatory, antioxidant and anti-senescence activities using colorimetric and fluorescence-based assays, fluorescence imaging, RT-qPCR and proteome profiler kit. The ZER-LCNs successfully reduced the expression of pro-inflammatory markers including Il-6 , Il-1β and Tnf-α , as well as the production of nitric oxide in RAW 264.7 cells. Additionally, ZER-LCNs successfully inhibited oxidative stress through reduction of reactive oxygen species (ROS) levels and regulation of genes, namely GPX2 and GCLC in BCi-NS1.1 cells. Anti-senescence activity of ZER-LCNs was also observed in BCi-NS1.1 cells, with significant reductions in the expression of SIRT1 , CDKN1A and CDKN2A . This study demonstrates strong in vitro anti-inflammatory, antioxidative and anti-senescence activities of ZER-LCNs paving the path for this formulation to be translated into a promising therapeutic agent for chronic respiratory inflammatory conditions including COPD and asthma.

Bibliographic Information

JournalNaunyn-Schmiedeberg's Archives of Pharmacology
PublisherSpringer
Publication Date2024-04-01
Publication Year2024
Volume397
Issue4
Pages2465-2483
Document TypeJournal Article
Print ISSN0028-1298
eISSN1432-1912
DOI10.1007/s00210-023-02760-7

Access Information

NARA Access Coverage1873-01-01~Current
Journal Homepagehttps://www.springer.com/journal/210
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.